New startup ideas · Health and bio · Healthcare and bio
startup idea
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
- AI agent as a service
- Enterprise
- $100B+ market
- Platform others build on
- US first
5/5
venture judge
10
similar startups, last 2 years (22 all-time)
97%
of 4 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Test it before you build it
$1,500 · 6 weeks · 25 prospects
For about $1,500 in six weeks, prove that two mid-size health systems will pay $2,500 up front plus 15% of recovered dollars for hand-run orthopedic denial appeals, before any agent is built.
1Focus group: who and where
The VP of revenue cycle or director of denials management at a US health system of 200 to 600 beds with an orthopedic surgery line, whose team is writing prior-auth and medical-necessity appeals by hand and writing off denials older than 90 days every quarter
where to find 25 · LinkedIn Sales Navigator filtered to 'VP revenue cycle' and 'director denials management' at Hospitals and Health Care companies with 1,000 to 10,000 employees; HFMA regional chapter events and the HFMA member directory; AAHAM chapter meetings; the Becker's Hospital Review revenue cycle coverage list for warm-up context
2Sell first, build later
A 90-day design-partner pilot sold before any software exists: Overturn takes every orthopedic surgery denial from the last 120 days, files appeals with payer-policy citations within 10 business days of intake, and reports overturn rate and dollars recovered monthly, starting within 30 days of signature
the ask · 15% of dollars actually recovered, with a $2,500 pilot deposit invoiced up front and credited against the first contingency invoice
a real yes · A real yes is a countersigned pilot agreement with a BAA, a start date and the $2,500 deposit paid; 'send us more information', a security questionnaire with no signature, and an unpaid trial request do not count
3Small experiments
The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.
1. Free denial teardown offer
$150 · 14 days
Message 25 revenue cycle VPs through Sales Navigator and two HFMA chapter events with one offer: send 10 redacted orthopedic denials and within 5 business days you get back draft appeal letters citing the governing payer medical policy, free. The founders write every letter by hand using publicly posted payer policies from UnitedHealthcare, Aetna and Cigna.
keep going if · 8 of 25 VPs send redacted denials; teardowns judge 30%+ of them overturnable
2. Fifteen pilot scoping calls
$350 · 21 days
Book 30-minute calls with every VP who engaged, walk a clickable Figma mock of the appeal queue and outcome dashboard, and present the one-page pilot offer: 50 orthopedic denials, 15% of dollars recovered, $2,500 deposit, start date within 30 days. Ask for the scoping session with their denial file on every call.
keep going if · 6 of 15 calls end with a scheduled scoping session where they commit to pulling their ortho denial data
3. Paid concierge appeal pilot
$500 · 30 days
Sign two systems and file real appeals on 25 to 50 orthopedic denials each, entirely by hand behind a shared inbox: pull the payer policy, assemble the record the client exports, write and submit the appeal, log every outcome. This is the Wizard-of-Oz version of the agent and it also produces the first labelled outcome data.
keep going if · 2 signed pilot agreements with BAAs, start dates and the $2,500 deposit received before work begins
4Collect a deposit up front
Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.
$2,500
per prospect, refundable
how · A $2,500 pilot deposit on a one-page design-partner agreement plus BAA, invoiced through Stripe and signed by the VP of revenue cycle, sized to sit under most departmental sign-off thresholds so procurement is not triggered set up: Stripe Invoicing ↗
what it reserves · One of three design-partner slots, the 15% contingency rate locked for the first contract year, and first position in the appeal queue
refund · Refunded in full if Overturn files fewer than 25 appeals in the first 30 days of the pilot
target · 2 paid deposits from 25 VP conversations within 45 days
Go: build it if
2 systems pay $2,500 with signed start dates and the teardowns show 30%+ of ortho denials overturnable with policy citations: build the agent on top of the manual workflow
Kill: stop if
25 VPs contacted, fewer than 5 send denials, zero deposits paid, or teardowns show under 15% overturnable: either access or economics fails, stop
Would you run this test?
One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.
Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
87
Idea Score, 0-100 · raw 53.0 x 1.64
Crowded
competition: more crowded than 72% of ideas · headwind x0.64
+3.2
government priorities, secondary (23 matching grants)
Trend
69
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)84
- Rounds announced 2025+ in the sector68
- Sector direction (live batch)100
- 2026 trend analyst25
Demand
77
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain100
100x potential
89
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge100
- Market size axis100
- Moat axis100
- Neighbours still alive60
- Technologist judge75
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were fight, payer, denials, health, sell, deploys, workforce, revenue.
The idea in full
- What
- Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure. Every filed appeal returns a labelled outcome, so the system learns which argument, citation and level of review overturns which payer under which policy version and state law. That outcome graph is then exposed as an API that RCM vendors and specialty billing platforms call, which is where the platform revenue comes from.
- Why now
- The 2026 cohorts show buyers accepting agents that do regulated back-office work end to end: Panacea (yc X26) sells AI-native FDA regulatory services, Harbor (yc X26) an AI-native CRO, Radley (yc S26) an AI-native radiology practice, and Lattice Health (yc X26) exists only because deployed clinical AI now needs governance.
- Wedge: first customer and entry point
- One service line at one mid-size system, orthopedic surgery prior-auth denials, priced as a share of dollars recovered so the first contract needs no budget line.
- Path to 100x
- US administrative and revenue-cycle spend is a $100B+ market and denial appeals are the part with a hard, dollar-denominated outcome label on every transaction. Whoever accumulates the largest labelled corpus of what overturns which payer becomes the layer every other billing product calls, which is the platform, and the corpus compounds faster than any single system can build alone.
- Ceiling
- Health systems insource the agents once the workflow is obvious and Overturn is repriced from outcome share to a per-appeal utility fee.
- Closest real companies, as the generator saw them
- Panacea automates regulatory submissions for sponsors and Harbor automates trial operations, both sponsor-side. Hubble supplies record retrieval, which Overturn consumes rather than competes with; the difference is that Overturn keeps the adjudicated outcome of every argument it files.
- Main risk
- Payers deploy the mirror-image agent and appeal outcomes stop correlating with anything learnable, collapsing the data moat to a cost saving.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
5/5
Every appeal returns a dollar-labelled outcome, so the corpus compounds into an API layer other billing vendors call inside a $100B+ spend.
Bootstrapper
4/5
Priced as a share of dollars recovered, so the first mid-size system needs no budget line and denials are an existing spend.
Operator
5/5
Denial appeals are frequent, dollar-labelled and already staffed; priced as a share of recovery to a revenue-cycle VP who needs no new budget.
Technologist
4/5
The appeal outcome graph is a genuine usage-grown asset, though the agent layer itself sits on commodity models over EHR integrations.
Risk
3/5
Outcome-share pricing and contingent revenue sit on EHR and clearinghouse integrations the health system controls, and insourcing repricing is the stated ceiling.
trends
2/5
Rides the vertical AI agents cluster the data shows crowded and cooling (batch share down 33% to 25%) with no dated shift behind the why-now.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (fight, payer, denials, health, sell, deploys, workforce, revenue): 22 all-time, 10 from the last two years. Same matching as Idea Check.
PromptWrx | AI-Powered Revenue Cycle Management
Workflow software for solar & energy contractors ☀️😎
Workforce platform to recruit, license, credential & manage clinicians
AI Revenue Engine for the Equipment Industry
The commerce intelligence layer for e-commerce brands that sell more with AI
Make every FDE on your team capable of moving any account forward.
AI to run behavioral health programs better
Real-time AI Compliance & Revenue Integrity for Medical Providers
AI Agents to win denied health insurance claims.
AI Revenue Platform for Post-Acute Care
Automated revenue cycle management, starting with dentists
Building the AI workforce for dental clinics.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1127
startup-relevant grants in Healthcare and bio
$590M
awarded in the sector, tracked
130
opportunities open now in the sector
- Personalized Diabetes Management through iPSC-Derived β-cells: A Tailored Approach for Improving Treatment Efficacy in Economically Vulnerable Populationsawardhigh relevance
NIH / NIDDK · SBIR phase I · $307K · posted 2026-08-15
- CAREER: Multimodal Generative AI for Autonomous Biomolecular Design and Accelerated Discoveryawardhigh relevance
National Science Foundation · Info Integration & Informatics · $758K · posted 2026-05-25
National Science Foundation · ART-Accelerating Rsrch Trnsltn · $6M · posted 2026-08-21
- EPSCoR Research Fellows: NSF: Capturing Transient Metal Cycling in Soils and Groundwater through Real-Time Electrochemical Measurementsawardmedium relevance
National Science Foundation · EPSCoR RII: EPSCoR Research Fe · $243K · posted 2026-08-18
- Collaborative Research: VINES: Track 1:Quantum-Ready and AI-Enabled by Design: Resilient and Deployable Next-Gen Cellular Networksawardmedium relevance
National Science Foundation · Use-Inspired NextG · $333K · posted 2026-08-02
- Collaborative Research: VINES: Track 1:Quantum-Ready and AI-Enabled by Design: Resilient and Deployable Next-Gen Cellular Networksawardmedium relevance
National Science Foundation · Use-Inspired NextG · $307K · posted 2026-08-02
- Collaborative Research: VINES: Track 1:Quantum-Ready and AI-Enabled by Design: Resilient and Deployable Next-Gen Cellular Networksawardmedium relevance
National Science Foundation · Use-Inspired NextG · $560K · posted 2026-08-02
- CSR:FET: Artificial Non-Neural Networks: Energy-Efficient Bacteria-Inspired AI for Edge Computingawardmedium relevance
National Science Foundation · CSR-Computer Systems Research · $782K · posted 2026-07-29
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 130 → 118 → 216 → 173 → 71 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 21 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Enterprise
- Business model
- AI agent as a service
- Path to 100x
- Platform others build on
- Market size
- $100B+ market
- Capital intensity
- Capital-light (software margins)
- Speed to revenue
- Revenue in 1-3 years
- Technical depth
- Integrations, no-code
- Go-to-market
- Founder-led sales
- Moat
- Data moat
- Geography
- US first
- Regulation
- Some regulation
- Vibe
- Hot space
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Health and bio · Healthcare and bio
Claimsmith
The agent platform where healthcare's back office gets rebuilt by everyone but us.
Claimsmith is a no-code platform where hospitals, billing companies, and health IT vendors build and run AI agents for administrative work: eligibility checks, prior authorization, claims appeals, and records chasing.
Fictional company written 2026-08-22 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.